Cordycepin: A bioactive metabolite with therapeutic potential

Life Sciences

Volumn 93, Issue 23, 2013, Pages 863-869

  Tuli, Hardeep S ^a   Sharma, Anil K ^a   Sandhu, Sardul S ^b   Kashyap, Dharambir ^c  

^a MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

^b RANI DURGAVATI UNIVERSITY   (India)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cordycepin; Cordyceps; Mechanism; Metabolite; Therapeutic potential

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIMETASTATIC AGENT; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CHEMOKINE RECEPTOR CXCR2; CORDYCEPIN; CYCLIN D1; GAMMA INTERFERON; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CORDYCEPS; CYTOKINE PRODUCTION; DNA FRAGMENTATION; DNA SYNTHESIS; G2 PHASE CELL CYCLE CHECKPOINT; METABOLITE; METASTASIS INHIBITION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PURINE METABOLISM; PURINE SYNTHESIS; REVIEW; RNA SYNTHESIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; SURVIVAL TIME; THROMBOCYTE AGGREGATION; UPREGULATION;

CORDYCEPIN; CORDYCEPS; MECHANISM; METABOLITE; THERAPEUTIC POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CORDYCEPS; DEOXYADENOSINES; DRUG DESIGN; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS;

CORDYCEPS; CORDYCEPS MILITARIS; FUNGI; HEXAPODA;

EID: 84887998354     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.09.030     Document Type: Review

References (69)

1. J.I. Arias, M.A. Aller, and J. Arias Cancer cell: using inflammation to invade the host Mol Cancer 6 2007 29 38
2. L. Armstrong, N. Jordan, and A. Millar Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes Thorax 51 1996 143 146
3. J.S. Baik, H.Y. Kwon, K.S. Kim, Y.K. Jeong, Y.S. Cho, and Y.C. Lee Cordycepin induces apoptosis in human neuroblastoma SK-N-BE(2)-C and melanoma SK-MEL-2 cells Indian J Biochem Biophys 49 2012 86 91
4. N.M. Bambace, and C.E. Holmes The platelet contribution to cancer progression J Thromb Haemost 9 2011 237 249
5. W. Cai, Q. Ye, L. Tang, B. Yu, and M. Zheng The effect of cordycepin alone or combined with chemotherapy on the proliferation, migration and apoptosis induction of colon cancer cells in vitro Chin J Clin 5 2011 4048 4056
6. C. Chavey, F. Bibeau, S. Gourgou-Bourgade, S. Burlinchon, F. Boissière, and D. Laune Oestrogen receptor negative breast cancers exhibit high cytokine content Breast Cancer Res 9 2007 R15
7. L.S. Chen, C.M. Stellrecht, and V. Gandhi RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells Br J Haematol 140 2008 682 687
8. H.J. Cho, J.Y. Cho, M.H. Rhee, C.R. Lim, and H.J. Park Cordycepin (3′-deoxyadenosine) inhibits human platelet aggregation induced by U46619, a TXA2 analogue J Pharm Pharmacol 58 2006 1677 1685
9. H.J. Cho, J.Y. Cho, M.H. Rhee, H.S. Kim, H.S. Lee, and H.J. Park Inhibitory effects of cordycepin (3′-deoxyadenosine), a component of Cordyceps militaris, on human platelet aggregation induced by thapsigargin J Microbiol Biotechnol 17 2007 1134 1138
10. H.J. Cho, J.Y. Cho, M.H. Rhee, and H.J. Park Cordycepin (3′-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner Eur J Pharmacol 558 2007 43 48
11. S. Choi, M.H. Lim, K.M. Kim, B.H. Jeon, W.O. Song, and T.W. Kim Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of the estrogen receptor Toxicol Appl Pharmacol 257 2011 165 168
12. T.W. Chung, S.K. Moon, Y.C. Chang, J.H. Ko, Y.C. Lee, and G. Cho Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism FASEB J 18 2004 1670 1681
13. J. Cui, R. Culbertson, Z. Mao, and B. Mock A novel therapeutic treatment utilizing cordycepin and cladribine synergy to decrease adverse treatment effects in various cancer cell lines JESS 2 2013 20 24
14. F.Q. Cunha, S. Moncadas, and F.Y. Liew Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages Biochem Biophys Res Commun 14 1992 1155 1159
15. K.G. Cunningham, W. Manson, F.S. Spring, and S.A. Hutchinson Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) link Nature 166 1950 949 954
16. P. Doetsch, J.M. Wu, Y. Sawada, and R.J. Suhadolnik Synthesis and characterization of (2′-5′)pp p3′dA(p3′dA)n, an analogue of (2′-5′)pppA(pA)n Nature 291 1981 355 358
17. P.W. Doetsch, R.J. Suhadolnik, Y. Sawada, J.D. Mosca, M.B. Flick, and N.L. Reichenbach Core (2′-5′)oligoadenylate and the cordycepin analog: inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes in the absence of interferon Proc Natl Acad Sci 78 1981 6699 6703
18. S. Dokka, X. Shi, S. Leonard, L. Wang, V. Castranova, and Y. Rojanasakul Interleukin-10-mediated inhibition of free radical generation in macrophages Am J Physiol Lung Cell Mol Physiol 280 2001 1196 1202
19. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 2002 161 174
20. B. Farrow, Y. Sugiyama, A. Chen, E. Uffort, W. Nealon, and B.E. Mark Inflammatory mechanisms contributing to pancreatic cancer development Ann Surg 239 2004 763 766
21. H.A. Goubran, and T. Burnouf Platelets, coagulation and cancer: multifaceted interactions Am Med J 3 2012 130 140
22. W. He, M.F. Zhang, J. Ye, T.T. Jiang, X. Fang, and Y. Song Cordycepin induces apoptosis by enhancing JNK and p38 kinase activity and increasing the protein expression of Bcl-2 pro-apoptotic molecules Biomed Biotechnol 11 2010 654 656
23. S. Holbein, A. Wengi, L. Decourty, F.M. Freimoser, A. Jacquier, and B. DichtlrnaI Cordycepin interferes with 3′ end formation in yeast independently of its potential to terminate RNA chain elongation RNA 15 2009 837 849
24. S. Hong, K.K. Park, J. Magae, K. Ando, T.S. Lee, and T.K. Kwon Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells J Biol Chem 280 2005 25202 25207
25. L. Huang, Q. Li, Y. Chen, X. Wang, and X. Zhou Determination and analysis of cordycepin and adenosine in the products of Cordyceps spp Afr J Microbiol Res 3 2009 957 961
26. K.W. Hunter, N.P.S. Crawford, and J. Alsarraj Mechanisms of metastasis Breast Cancer Res 10 2008 S2
27. P. Imesch, R. Hornung, D. Fink, and A. Fedier Cordycepin (3′-deoxyadenosine), an inhibitor of mRNA polyadenylation, suppresses proliferation and activates apoptosis in human epithelial endometriotic cells in vitro Gynecol Obstet Invest 72 2011 43 49
28. S.P. Jackson The growing complexity of platelet aggregation Blood 109 2007 5087 5088
29. D.V. Jagger, N.M. Kredich, and A.J. Guarino Inhibition of Ehrlich mouse ascitis tumor growth by cordycepin Cancer Res 21 1961 216 220
30. W.H. Janek, Q. Shi, and C.M. Kearney Cordycepin/hydroxyurea synergy allows low dosage efficacy of cordycepin in MOLT-4 leukemia cells Anticancer Res 27 2007 3143 3146
31. J.W. Jeong, C.Y. Jin, G.Y. Kim, J.D. Lee, C. Park, and G.D. Kim Anti-inflammatory effects of cordycepin via suppression of inflammatory mediators in BV2 microglial cells Int Immunopharmacol 10 2010 1580 1586
32. J.W. Jeong, C.Y. Jin, C. Park, S.H. Hong, G.Y. Kim, and Y.K. Jeong Induction of apoptosis by cordycepin via reactive oxygen species generation in human leukemia cells Toxicol In Vitro 25 2011 817 824
33. J.W. Jeong, C.Y. Jin, C. Park, M.H. Han, G.Y. Kim, and S.K. Moon Inhibition of migration and invasion of LNCaP human prostate carcinoma cells by cordycepin through inactivation of Akt Int J Oncol 40 2012 1697 1704
34. S.M. Jung, S.S. Park, W.J. Kim, and S.K. Moon Ras/ERK1 pathway regulation of p27KIP1-mediated G1-phase cell-cycle arrest in cordycepin-induced inhibition of the proliferation of vascular smooth muscle cells Eur J Pharmacol 681 2012 15 22
35. H.G. Kim, B. Shrestha, S.Y. Lim, D.H. Yoon, W.C. Chang, and D.J. Shin Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappa β through Akt and p38 inhibition in RAW 264.7 macrophage cells Eur J Pharmacol 18 2006 192 197
36. H. Kim, A.S. Naura, Y. Errami, J. Ju, and A.H. Boulares Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP Mol Med 17 2011 893 897
37. H. Klenow Formation of the mono-, di- and triphosphate of cordycepin in Ehrlich ascites-tumor cells in vitro Biochim Biophys Acta 76 1963 347 353
38. S.J. Lee, S.K. Kim, W.S. Choi, W.J. Kim, and S.K. Moon Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells Arch Biochem Biophys 490 2009 103 106
39. E.J. Lee, W.J. Kim, and S.K. Moon Cordycepin suppresses TNF-alpha-induced invasion, migration and matrix metalloproteinase-9 expression in human bladder cancer cells Phytother Res 24 2010 1755 1756
40. S.J. Lee, G.S. Moon, K.H. Jung, W.J. Kim, and S.K. Moon c-Jun N-terminal kinase 1 is required for cordycepin-mediated induction of G2/M cell-cycle arrest via p21WAF1 expression in human colon cancer cells Food Chem Toxicol 48 2010 277 283
41. H.J. Lee, P. Burger, M. Vogel, K. Friese, and A. Bruning The nucleoside antagonist cordycepin causes DNA double strand breaks in breast cancer cells Invest New Drugs 30 2012 1917 1918
42. H. Meena, M. Mohsin, H.K. Pandey, P.S. Negi, and Z. Ahmed Estimation of cordycepin by improved HPLC method in the natural and cultured mycelia of high medicinal value Himalayan entomogenous fungus Cordyceps sinensis EJEAFChe 9 2010 1598 1603
43. P.M. Mertz, D.L.D. Witt, W.G. Stetler-Stevenson, and L.M. Wahl Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production J Biol Chem 269 1994 21322 21327
44. K.W. Moore, A. Ogarra, D. Waal, and R. Malefet Interleukin-10 Annu Rev Immunol 11 1993 165 190
45. W.E.G. Muller, B.E. Weiler, R. Charubala, W. Pfleiderer, L. Leserman, and R.W. Sobol Cordycepin analogues of 2,5′-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase Biochemistry 30 1991 2027 2033
46. M. Nakajima, D.R. Welch, P.N. Belloni, and G.L. Nicolson Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials Cancer Res 47 1987 4869 4876
47. W.G. Nelson, A.M.M. De, T.L.W. De, and W.B. Isaacs The role of inflammation in the pathogenesis of prostate cancer J Urol 172 2004 S6 S11
48. E.M. Noh, H.J. Youn, S.H. Jung, J.H. Han, Y.J. Jeong, and E.Y. Chung Cordycepin inhibits TPA-induced matrix metalloproteinase-9 expression by suppressing the MAPK/AP-1 pathway in MCF-7 human breast cancer cells Int J Mol Med 25 2010 255 260
49. K.H. Overgaard The inhibition of 5-phosphoribosyl-1-pyrophosphate formation by cordycepin triphosphate in extracts of Ehrlich ascites tumor cells Biochim Biophys Acta 80 1964 504 507
50. R.R. Paterson Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry 69 2008 1469 1495
51. Y.K. Rao, S.H. Fang, W.S. Wu, and Y.M. Tzeng Constituents isolated from Cordyceps militaris suppress enhanced inflammatory mediator's production and human cancer cell proliferation J Ethnopharmacol 131 2010 363 364
52. E.R. Rayburn, S.J. Ezell, and R. Zhang Anti-inflammatory agents for cancer therapy Mol Cell Pharmacol 1 2009 29 43
53. F. Rottman, and A.J. Guarino The inhibition of phosphoribosyl- pyrophosphate amidotransferase activity by cordycepin monophosphate Biochim Biophys Acta 89 1964 465 468
54. A.A. Saboury, A. Divsalar, G.A. Jafari, A.A. Moosavi-Movahedi, M.R. Housaindokht, and G.H. Hakimelahi A product inhibition study on adenosine deaminase by spectroscopy and calorimetry J Biochem Mol Biol 35 2002 302 303
55. H. Sawai, J. Imai, K. Lesiak, M.I. Johnston, and P.F. Torrence Cordycepin analogues of 2-5A and its derivatives. Chemical synthesis and biological activity J Biol Chem 258 1983 1671 1676
56. S. Shin, S. Moon, Y. Park, J. Kwon, S. Lee, and C.K. Lee Role of cordycepin and adenosine on the phenotypic switch of macrophages via induced anti-inflammatory cytokines Immune Netw 9 2009 255 259
57. T. Tsuruo, and N. Fujita Platelet aggregation in the formation of tumor metastasis Proc Jpn Acad Ser B Phys Biol Sci 84 2008 189 198
58. H.S. Tuli, S.S. Sandhu, and A.K. Sharma Pharmacological and therapeutic potential of Cordyceps with special reference to cordycepin Biotechnology 3 2013 10.1007/s13205-013-0121-9
59. D. Wang, R.N. Dubois, and A. Richmond The role of chemokines in intestinal inflammation and cancer Curr Opin Pharmacol 9 2009 189 198
60. H.P. Wei, X.L. Ye, Z. Chen, Y.J. Zhong, P.M. Li, and S.C. Pu Synthesis and pharmacokinetic evaluation of novel N-acyl-cordycepin derivatives with a normal alkyl chain Eur J Med Chem 44 2009 665 669
61. J.F.J. Woessner Matrix metalloproteinases and their inhibitors in connective tissue remodeling FASEB J 5 1991 2145 2149
62. Y.Y. Wong, A. Moon, R. Duffin, A. Barthet-Barateig, H.A. Meijer, and M.J. Clemens Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction J Biol Chem 285 2010 2610 2611
63. M.S. Woo, S.H. Jung, S.Y. Kim, J.W. Hyun, K.H. Ko, and W.K. Kim Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells Biochem Biophys Res Commun 335 2005 1017 1018
64. W.C. Wu, J.R. Hsiao, Y.Y. Lian, C.Y. Lin, and B.M. Huang The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line Cancer Chemother Pharmacol 60 2007 103 108
65. J.W. Xie, L.F. Huang, W. Hu, Y.B. He, and K.P. Wong Analysis of the main nucleosides in Cordyceps sinensis by LC/ESI-MS Molecules 15 2010 305 309
66. H. Yan, D. Zhu, D. Xu, J. Wu, and X. Bian A study on Cordyceps militaris polysaccharide purification, composition and activity analysis Afr J Biotechnol 7 2008 4004 4005
67. N. Yoshikawa, M. Kunitomo, S. Kagota, K. Shinozuka, and K. Nakamura Inhibitory effect of cordycepin on hematogenic metastasis of B16-F1 mouse melanoma cells accelerated by adenosine-5′-diphosphate Anticancer Res 29 2009 3857 3860
68. S. Zhong, H. Pan, L. Fan, G. Lv, Y. Wu, and B. Parmeswaran Advances in research of polysaccharides in Cordyceps species Food Technol Biotechnol 47 2009 304 308
69. X. Zhou, C.U. Meyer, P. Schmidtke, and F. Zepp Effect of cordycepin on interleukin-10 production of human peripheral blood mononuclear cells Eur J Pharmacol 453 2002 309 317